Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Poortmans

Showing results (41-50 of 257) with videos related to

Pageof 26
Sort By:
Breast Care (Basel, Switzerland)|June 16, 2022
Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?Gerd Fastner, David Krug, Icro Meattini, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 19, 2025
Can the daily position of bolus material influence radiotherapy treatment?Ghizela A-M Salagean, Zoltán Bálint, Philip Poortmans, et al.
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Local Treatment of Triple-Negative Breast CancerMelanie Machiels, Orit Kaidar-Person, Isabel T Rubio, et al.
Lancet (London, England)|April 4, 2021
Breast cancerSibylle Loibl, Philip Poortmans, Monica Morrow, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 14, 2014
Clinical and technological transition in breast cancerPhilip Poortmans, Hugo Marsiglia, Manuel De Las Heras, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case reviewFatma Ataman, Philip Poortmans, Roger Stupp, et al.
Practical Radiation Oncology|November 1, 2024
In Regard to Shaitelman et alOrit Kaidar-Person, Vratislav Strnad, Ivica Ratosa, et al.
The Lancet. Oncology|May 7, 2015
Radiotherapy for elderly patients with low-risk breast cancerOrit Kaidar-Person, Philip Poortmans, Abraham Kuten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2023
Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trialsOmran Saifi, Bachir Bachir, Joseph Panoff, et al.
Lancet (London, England)|May 20, 2014
Radiotherapy for breast cancer, the TARGIT-A trialJohn Yarnold, Birgitte Vrou Offersen, Ivo Olivotto, et al.
Pageof 26

Showing results (41-50 of 257) with videos related to

Sort By:
Pageof 26
Breast Care (Basel, Switzerland)|June 16, 2022
Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?Gerd Fastner, David Krug, Icro Meattini, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 19, 2025
Can the daily position of bolus material influence radiotherapy treatment?Ghizela A-M Salagean, Zoltán Bálint, Philip Poortmans, et al.
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Local Treatment of Triple-Negative Breast CancerMelanie Machiels, Orit Kaidar-Person, Isabel T Rubio, et al.
Lancet (London, England)|April 4, 2021
Breast cancerSibylle Loibl, Philip Poortmans, Monica Morrow, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 14, 2014
Clinical and technological transition in breast cancerPhilip Poortmans, Hugo Marsiglia, Manuel De Las Heras, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case reviewFatma Ataman, Philip Poortmans, Roger Stupp, et al.
Practical Radiation Oncology|November 1, 2024
In Regard to Shaitelman et alOrit Kaidar-Person, Vratislav Strnad, Ivica Ratosa, et al.
The Lancet. Oncology|May 7, 2015
Radiotherapy for elderly patients with low-risk breast cancerOrit Kaidar-Person, Philip Poortmans, Abraham Kuten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2023
Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trialsOmran Saifi, Bachir Bachir, Joseph Panoff, et al.
Lancet (London, England)|May 20, 2014
Radiotherapy for breast cancer, the TARGIT-A trialJohn Yarnold, Birgitte Vrou Offersen, Ivo Olivotto, et al.
Pageof 26